The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo

被引：0
|
作者：
Okada, Masashi [1 ]
Suzuki, Shuhei [1 ]
Seino, Manabu
Takeda, Hiroyuki [1 ]
Kitanaka, Chifumi
机构：
[1] Yamagata Univ, Sch Med, Mol Can Sci, Yamagata, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
cancer stem cell; Xenograft;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1197
引用
收藏
页码：269 / 269
页数：1
相关论文
共 50 条
  • [1] The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo
    Okada, Masashi
    Kuramoto, Kenta
    Takeda, Hiroyuki
    Watarai, Hikaru
    Sakaki, Hirotsugu
    Seino, Shizuka
    Seino, Manabu
    Suzuki, Shuhei
    Kitanaka, Chifumi
    ONCOTARGET, 2016, 7 (19) : 27021 - 27032
  • [2] The JNK inhibitor AS602801 Synergizes with Enzalutamide to Kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression
    Li, Zhenghong
    Sun, Carrie
    Tao, Sijia
    Osunkoya, Adeboye O.
    Arnold, Rebecca S.
    Petros, John A.
    Zu, Xiongbing
    Moreno, Carlos S.
    TRANSLATIONAL ONCOLOGY, 2020, 13 (04):
  • [3] Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models
    Palmer, Stephen S.
    Altan, Melis
    Denis, Deborah
    Tos, Enrico Gillio
    Gotteland, Jean-Pierre
    Osteen, Kevin G.
    Bruner-Tran, Kaylon L.
    Nataraja, Selvaraj G.
    REPRODUCTIVE SCIENCES, 2016, 23 (01) : 11 - 23
  • [4] Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models
    Stephen S. Palmer
    Melis Altan
    Deborah Denis
    Enrico Gillio Tos
    Jean-Pierre Gotteland
    Kevin G. Osteen
    Kaylon L. Bruner-Tran
    Selvaraj G. Nataraja
    Reproductive Sciences, 2016, 23 : 11 - 23
  • [5] AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1
    Yamamoto, Masahiro
    Suzuki, Shuhei
    Togashi, Keita
    Sanomachi, Tomomi
    Seino, Shizuka
    Kitanaka, Chifumi
    Okada, Masashi
    ANTICANCER RESEARCH, 2019, 39 (02) : 609 - 617
  • [6] AS602801, an Anti-Cancer Stem Cell Drug Candidate, Suppresses Gap-junction Communication Between Lung Cancer Stem Cells and Astrocytes
    Kuramoto, Kenta
    Yamamoto, Masahiro
    Suzuki, Shuhei
    Sanomachi, Tomomi
    Togashi, Keita
    Seino, Shizuka
    Kitanaka, Chifumi
    Okada, Masashi
    ANTICANCER RESEARCH, 2018, 38 (09) : 5093 - 5099
  • [7] AS602801, an Anticancer Stem Cell Candidate Drug, Reduces Survivin Expression and Sensitizes A2780 Ovarian Cancer Stem Cells to Carboplatin and Paclitaxel
    Yamamoto, Masahiro
    Suzuki, Shuhei
    Togashi, Keita
    Sanomachi, Tomomi
    Seino, Shizuka
    Kitanaka, Chifumi
    Okada, Masashi
    ANTICANCER RESEARCH, 2018, 38 (12) : 6699 - 6706
  • [8] Leelamine Is a Novel Lipogenesis Inhibitor in Prostate Cancer Cells In Vitro and In Vivo
    Singh, Krishna B.
    Hahm, Eun-Ryeong
    Pore, Subrata K.
    Singh, Shivendra, V
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (10) : 1800 - 1810
  • [9] Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo
    Liu, Xinyu
    Li, Wenjing
    Xu, Licheng
    Chen, Xiaoxue
    Zhao, Rui
    Guo, Yan
    Ge, Jingchun
    Yang, Zhenming
    Li, Liang
    Zhang, Jiarui
    Cao, Jing
    Shao, Yue
    Guo, Xinyue
    Tian, Linli
    Liu, Ming
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2023, 158
  • [10] HDAC inhibitor SAHA suppressed beast cancer stem cells in vitro and in vivo
    Lee, Hsiu-Fang
    CANCER RESEARCH, 2011, 71
12345